MONTREAL, CANADA -- (MARKET WIRE) -- May 01, 2007 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced that Mark Beaudet, Vice President and co-founder will present a corporate update at the 2007 UBS Global Generic and Specialty Pharmaceuticals Conference on Tuesday, May 8th, 2007 at 12:30 p.m. ET, at the Grand Hyatt New York. A copy of the presentation will be available at www.paladinlabs.com.
